Brookstone Capital Management Maia Biotechnology, Inc. Put Options Transaction History
Brookstone Capital Management
- $5.32 Billion
- Q2 2024
Put Options
0 transactions
Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
---|
Others Institutions Holding MAIA
# of Institutions
22Shares Held
1.79MCall Options Held
0Put Options Held
0-
Halter Ferguson Financial Inc. Carmel, IN722KShares$1.83 Million1.75% of portfolio
-
Vanguard Group Inc Valley Forge, PA537KShares$1.36 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA157KShares$396,5570.0% of portfolio
-
Black Rock Inc. New York, NY78.5KShares$198,6580.0% of portfolio
-
Centric Wealth Management68.2KShares$172,5400.07% of portfolio
About MAIA Biotechnology, Inc.
- Ticker MAIA
- Exchange
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,935,900
- Market Cap $27.7M
- Description
- MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer, primarily non-small cell lung cancer. Its lead asset, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company wa...